ResearcherRoyal Brisbane and Women's HospitalNo recent work listed

Elizabeth Stephanie Ahern

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2062-5695; OpenAlex author ID A5042791176. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Pentixafor as a theranostic agent in rectal and pancreatic adenocarcinoma: outcomes from a pilot study Co-author DOI 10.21203/rs.3.rs-1274952/v2 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Nicholas O’Rourke · 1 shared paper, 2022 · strength 0.14
- Paper Pentixafor as a theranostic agent in rectal and pancreatic adenocarcinoma: outcomes from a pilot study DOI 10.21203/rs.3.rs-1274952/v2 ↗
David Cavallucci · 1 shared paper, 2022 · strength 0.14
- Paper Pentixafor as a theranostic agent in rectal and pancreatic adenocarcinoma: outcomes from a pilot study DOI 10.21203/rs.3.rs-1274952/v2 ↗
Matthew Burge · 1 shared paper, 2022 · strength 0.14
- Paper Pentixafor as a theranostic agent in rectal and pancreatic adenocarcinoma: outcomes from a pilot study DOI 10.21203/rs.3.rs-1274952/v2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.